These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22126650)

  • 1. Analysis of direct medical care costs of peptic ulcer disease in a Korean tertiary medical center.
    Kang JM; Seo PJ; Kim N; Lee BH; Kwon J; Lee DH; Jung HC
    Scand J Gastroenterol; 2012 Jan; 47(1):36-42. PubMed ID: 22126650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
    Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
    Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community.
    Sone Y; Kumada T; Toyoda H; Yokoyama M; Kato M; Asaka M
    Helicobacter; 2008 Oct; 13(5):346-51. PubMed ID: 19250509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
    Cherian PT; Cherian S; Singh P
    Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
    Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization.
    Levin TR; Schmittdiel JA; Henning JM; Kunz K; Henke CJ; Colby CJ; Selby JV
    Am J Gastroenterol; 1998 May; 93(5):743-7. PubMed ID: 9625120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease.
    Allison JE; Hurley LB; Hiatt RA; Levin TR; Ackerson LM; Lieu TA
    Arch Intern Med; 2003 May; 163(10):1165-71. PubMed ID: 12767952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of bleeding peptic ulcers: a prospective study.
    Liu NJ; Lee CS; Tang JH; Cheng HT; Chu YY; Sung KF; Lin CH; Tsou YK; Lien JM; Chen PC; Chiu CT; Cheng CL
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e340-7. PubMed ID: 17944885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology and treatment of childhood peptic ulcer disease in Taiwan: a single center 9-year experience.
    Huang SC; Sheu BS; Lee SC; Yang HB; Yang YJ
    J Formos Med Assoc; 2010 Jan; 109(1):75-81. PubMed ID: 20123589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.
    Musumba C; Jorgensen A; Sutton L; Van Eker D; Moorcroft J; Hopkins M; Pritchard DM; Pirmohamed M
    Aliment Pharmacol Ther; 2012 Jul; 36(1):48-56. PubMed ID: 22554233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease: results from a quality improvement project.
    Brock J; Sauaia A; Ahnen D; Marine W; Schluter W; Stevens BR; Scinto JD; Karp H; Bratzler D
    JAMA; 2001 Oct 24-31; 286(16):1985-93. PubMed ID: 11667935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing trends and characteristics of peptic ulcer disease: A multicenter study from 2010 to 2019 in Korea.
    Choi YJ; Kim TJ; Bang CS; Lee YK; Lee MW; Nam SY; Shin WG; Seo SI
    World J Gastroenterol; 2023 Nov; 29(44):5882-5893. PubMed ID: 38111504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease.
    Saxena A; Nath Prasad K; Chand Ghoshal U; Krishnani N; Roshan Bhagat M; Husain N
    Scand J Gastroenterol; 2008; 43(6):669-74. PubMed ID: 18569983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake.
    Charpignon C; Lesgourgues B; Pariente A; Nahon S; Pelaquier A; Gatineau-Sailliant G; Roucayrol AM; Courillon-Mallet A;
    Aliment Pharmacol Ther; 2013 Oct; 38(8):946-54. PubMed ID: 23981105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Recurrence Rates of Peptic Ulcers without Helicobacter pylori.
    Seo JH; Hong SJ; Kim JH; Kim BW; Jee SR; Chung WC; Shim KN; Baik GH; Kim SS; Kim SG; Kim JI
    Gut Liver; 2016 Sep; 10(5):719-25. PubMed ID: 27114412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
    al-Assi MT; Genta RM; Karttunen TJ; Graham DY
    Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A; Remacha B; Sáinz R; Hirschowitz BI
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Helicobacter pylori eradication indicated in cirrhotic patients with peptic ulcer disease?
    Villalan R; Maroju NK; Kate V; Ananthakrishnan N
    Trop Gastroenterol; 2006; 27(4):166-8. PubMed ID: 17542294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.